Soluble powder for treating respiratory diseases of livestock and poultry

A respiratory disease, soluble technology, applied in respiratory diseases, powder delivery, organic active ingredients, etc., can solve the problems of carcass quality degradation, egg production rate reduction, death and other problems, and achieve high safety, good oral absorption, and curative effect. real effect

Inactive Publication Date: 2014-06-04
QINGDAO KDN BIOTECH
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At the same time, due to the abuse of antibiotics in livestock and poultry farming, the problem of drug-resistant strains is becoming more and more serious
[0003] Taking respiratory diseases of livestock and poultry as an example, the outbreak of respiratory diseases has seriously affected the weight gain and feed utilization rate of livestock and poultry, resulting in lower egg production rate and lower carcass quality. Downgrading, even causing a considerable number of deaths, affecting the economic benefits of farmers

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] First, 20 g of tylosin tartrate, 5 g of trimethoprim and 975 g of auxiliary materials anhydrous glucose are crushed, and then passed through a 60-mesh sieve; Dilute and mix by incremental dilution method, pass through a 60-mesh fine sieve three times to obtain the mixture; mix the mixture with the remaining excipients evenly, pass the mixture through an 80-mesh fine sieve three times to obtain about 1KG of soluble powder, which contains Tylos tartrate Su 20g, trimethoprim 5g.

[0017] Usage and dosage: mixed drinking: add 0.7g of the medicine of the present invention to every 1 liter of water, use continuously for 5 days as a course of treatment, and double the amount for severe cases.

Embodiment 2

[0019] First, 25 g of tylosin tartrate, 10 g of trimethoprim and 965 g of auxiliary materials anhydrous glucose are crushed, and then passed through a 60-mesh sieve; Dilute and mix by incremental dilution method, pass through a 60-mesh fine sieve three times to obtain the mixture; mix the mixture with the remaining excipients evenly, pass the mixture through an 80-mesh fine sieve three times to obtain about 1KG of soluble powder, which contains Tylos tartrate Su 25g, trimethoprim 10g.

[0020] Usage and dosage: mixed drinking: add 0.5g of the medicine of the present invention to every 1 liter of water, use continuously for 5 days as a course of treatment, and double the amount for severe cases.

Embodiment 3

[0022] First, 30 g of tylosin tartrate, 15 g of trimethoprim and 955 g of auxiliary materials anhydrous glucose are crushed, and then passed through a 60-mesh sieve; Dilute and mix by incremental dilution method, pass through a 60-mesh fine sieve three times to obtain the mixture; mix the mixture with the remaining excipients evenly, pass the mixture through an 80-mesh fine sieve three times to obtain about 1KG of soluble powder, which contains Tylos tartrate Su 30g, trimethoprim 15g.

[0023] Usage and dosage: Mixed drinking: add 0.4g of the medicine of the present invention to every 1 liter of water, use continuously for 5 days as a course of treatment, and double the amount for severe cases.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Belonging to the technical field of veterinary medicines, the invention relates to a soluble powder for treating respiratory diseases of livestock and poultry. The soluble powder comprises tylosin tartrate, trimethoprim and auxiliary materials. As an antibiotic medicine, the medicine provided by the invention is mainly used for various respiratory tract infection and chronic respiratory diseases of livestock and poultry caused by mixed infection of sensitive bacteria and mycoplasmas. Tylosin tartrate and trimethoprim are adopted for compatible use to act on different sensitive bacteria and mycoplasmas at the same time, thus solving the drug resistance problem generated after single use of tylosin for treatment. The soluble powder provided by the invention has the advantages of good oral administration absorption and high safety.

Description

technical field [0001] The invention belongs to the field of veterinary medicine, in particular to a soluble powder for treating respiratory diseases of livestock and poultry. Background technique [0002] With the expansion of the scale of intensive farming, livestock and poultry have serious respiratory diseases, digestive system diseases and other diseases. At the same time, due to the abuse of antibiotics in livestock and poultry breeding, the problem of drug-resistant strains is becoming more and more serious. [0003] Taking respiratory diseases of livestock and poultry as an example, the outbreak of respiratory diseases seriously affects the weight gain and feed utilization rate of livestock and poultry, reduces the egg production rate, degrades the quality of carcass, and even causes a considerable number of deaths, which affects the economics of farmers. benefit. Poultry respiratory diseases are more complicated in poultry production, and there are many types o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61K31/505A61K9/14A61P11/00A61P31/04
CPCY02A40/70
Inventor 崔亮亮郝智慧刘元元
Owner QINGDAO KDN BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products